solanezumab

Biotech

Roche refreshingly cautious on Alzheimer's hopeful gantenerumab

Roche’s pharma CEO is not getting dragged into hype over its effort gantenerumab.
Ben Adams Feb 5, 2021 7:55am

Lilly and Roche's antibodies fail late-phase Alzheimer's test

Feb 10, 2020 6:51am

Analysts on amyloid thesis: It's not dead yet

Dec 9, 2016 4:51am

Lilly gives up on Alzheimer's hope solanezumab

Nov 23, 2016 8:08am

Alzheimer’s biotech Alzheon to move once-failed drug into new PhIII

Jul 25, 2016 9:30am